Horizon Therapeutics Past Performance

How has Horizon Therapeutics performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


62.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: HZNP has high quality earnings.

Growing Profit Margin: HZNP's current net profit margins (20.1%) are lower than last year (20.3%).


Past Earnings Growth Analysis

Earnings Trend: HZNP has become profitable over the past 5 years, growing earnings by 62.3% per year.

Accelerating Growth: HZNP's earnings growth over the past year (47.6%) is below its 5-year average (62.3% per year).

Earnings vs Industry: HZNP earnings growth over the past year (47.6%) exceeded the Biotechs industry 29.2%.


Return on Equity

High ROE: HZNP's Return on Equity (15.5%) is considered low.


Discover strong past performing companies